The synthesis, structural characterization, and in vitro anti-cancer activity of chloro(p-cymene) complexes of ruthenium(II) containing a disulfoxide ligand

Inorganica Chimica Acta

Volumn 352, Issue , 2003, Pages 238-246

  Huxham, Lynsey A ^a   Cheu, Elizabeth L S ^a   Patrick, Brian O ^a   James, Brian R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti cancer activity; Crystal structures; Disulfoxide ligands; p Cymene complexes; Ruthenium complexes

Indexed keywords

CELL CULTURE; CHELATION; CRYSTAL STRUCTURE; DISEASES; LIGANDS; SYNTHESIS (CHEMICAL); X RAY CRYSTALLOGRAPHY;

ANTICANCER ACTIVITIES; IN-VITRO TESTS; MAMMARY CANCER; MITOCHONDRIAL DEHYDROGENASE ACTIVITY; P-CYMENE; RUTHENIUM COMPLEXES; STRUCTURAL CHARACTERIZATION; SULFOXIDE GROUPS;

RUTHENIUM COMPOUNDS;

LIGAND; OXIDOREDUCTASE; RUTHENIUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CELL; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG ANALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; NITROBLUE TETRAZOLIUM TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; X RAY CRYSTALLOGRAPHY;

EID: 0041696963     PISSN: 00201693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-1693(03)00155-5     Document Type: Article

References (44)

1. Guo Z., Sadler P.J. Angew. Chem., Int. Ed. Engl. 38:1999;1512. and references therein.
2. Wang E., Giandomenico C.M. Chem. Rev. 99:1999;2451.
3. Jamieson E.R., Lippard S.J. Chem. Rev. 99:1999;2467.
4. Reedijk J. Chem. Rev. 99:1999;2499.
5. Clarke M.J., Galang R.D., Rodriguez V.M., Kumar R., Pell S., Bryan D.M. Nicolini M. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. 1988;582 Martinus Nijhoff Publishing, Boston, MA.
6. Clarke M.J., Zhu F., Frasca D.R. Chem. Rev. 99:1999;2511.
7. Aird R.E., Cummings J., Ritchie A.A., Muir M., Morris R.E., Chen H., Sadler P.J., Jodrell D.I. Br. J. Cancer. 86:2001;1652. and references therein.
8. Sava G., Zorzet S., Giraldi T., Mestroni G., Zassinovich G. Eur. J. Cancer Clin. Oncol. 20:1984;841.
9. Sava G., Pacor S., Zorzet S., Alessio E., Mestroni G. Pharm. Res. 21:1989;617.
10. Sava G., Alessio E., Bergamo A., Mestroni G. Clarke M.J., Sadler P.J. Metallopharmaceutical I, DNA Interactions. 1999;143 Springer-Verlag, Berlin.
11. Sava G., Alessio E., Bergamo A., Mestroni G. Top. Biol. Inorg. Chem. 1:1999;143.
12. Alessio E., Mestroni G., Nardin G., Attia W.M., Calligaris M., Sava G., Zorzet S. Inorg. Chem. 27:1988;4099.
13. Alessio E., Balducci G., Lutman A., Mestroni G., Calligaris M., Attia W.M. Inorg. Chim. Acta. 203:1993;205.
14. Chan P.K.L., Chan P.K.H., Frost D.C., James B.R., Skov K.A. Can. J. Chem. 66:1988;117.
15. Chan P.K.L., James B.R., Frost D.C., Chan P.K.H., Hu H.-L., Skov K.A. Can. J. Chem. 67:1989;508.
16. Yapp D.T.T., Rettig S.J., James B.R., Skov K.A. Inorg. Chem. 36:1997;5635.
17. E.L.S. Cheu, PhD dissertation, University of British Columbia, Vancouver, 2000. E.L.S. Cheu, S.J. Rettig, K.A. Skov, B.R. James, 81st Can. Soc. Chem. Conf., Whistler, BC, 1998, Abstract 459. E.L.S. Cheu, S.J. Rettig, K.A. Skov, B.R. James, 82nd Can. Soc. Chem. Conf., Toronto, ON, 1999, Abstract 260.
18. Dale L., Tocher J.H., Dyson T.M., Edwards D.I., Tocher D.A. Anti-Cancer Drug Des. 7:1992;3.
19. Vashisht Gopal Y.N., Jayaraju D., Kondapi A.K. Biochem. 38:1999;4382.
20. Korn S., Sheldrick W. Inorg. Chim. Acta. 254:1997;85.
21. Mosmann T.J. J. Immun. Methods. 65:1983;55.
22. C.S. Allardyce, P.J. Dyson, D.J. Ellis, S.L. Heath, Chem. Commun. (2001) 1396.
23. Morris R.E., Aird R.E., del Socorro Murdoch P., Chen H., Cummings J., Hughes N.D., Parsons S., Parkin A., Boyd G., Jodrell D.I., Sadler P.J. Med. Chem. 44:2001;3616 J. Cummings, R.E. Aird, R.E. Morris, H. Chen, P. del Socorro Murdoch, P.J. Sadler, J.F. Smyth, D.I. Jodrell, Clin. Cancer Res. 6 (2000), Abstract 142.
24. Hull M., Bargar T.W. J. Org. Chem. 40:1975;3152.
25. Khiar N., Araújo. C.S., Alcudia F., Fernández I. J. Ord. Chem. 67:2002;345.
26. C.S. Araujo, L.A. Huxham, N. Khiar, B.R. James, in press.
27. M.A. Bennett, A.K. Smith, J. Chem. Soc., Dalton Trans. (1974) 233.
28. Bennett M.A., Huang T.-N., Matheson T.W., Smith A.K. Inorg. Syn. 21:1982;74.
29. d*TREK, 4.13 ed., Molecular Structure Corporation, 1996-1998.
30. Bellamy W.T. Drugs. 44:1992;690.
31. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Cancer Res. 48:1988;589.
32. Calligaris M., Carugo O. Coord. Chem. Rev. 153:1996;83.
33. Calligaris M. Croat. Chem. Acta. 72:1999;147.
34. G. Orpen, L. Braumer, F.H. Allen, O. Kennard, D.G. Watson, J. Chem. Soc., Dalton Trans. (1989) S1.
35. Davies J.A. Adv. Inorg. Chem. Radiochem. 24:1981;115.
36. Geremia S., Calligaris M., Mestroni S. Inorg. Chim. Acta. 292:1999;144.
37. Calligaris M., Melchior A., Geremia S. Inorg. Chim. Acta. 323:2001;89.
38. Carvalho C.C., Francisco R.H.P., Gambardella M.T.P., de Souza G.F., Filgueiras C.A.L. Acta Crystallogr., C. 52:1996;1627. and references therein.
39. Francisco R.H.P., Gambardella M.T.P., Rodrigues A.M.D.D., de Souza G.F., Filgueiras C.A.L. Acta Crystallogr., C. 51:1995;604.
40. T. Tanase, T. Aiko, Y. Yamamoto, Chem. Commun. (1996) 2341. S. Geremia, G. Mestroni, M. Calligaris, E. Alessio, J. Chem. Soc., Dalton Trans. (1998) 2447.
41. Geary W.J. Coord. Chem. Rev. 7:1971;110.
42. Zelonka R.A., Baird M.C. Can. J. Chem. 50:1972;3063.
43. J. Sartor, L. Mayer, Personal communication (BC Cancer Research Centre), 2001.
44. Haimei C., Parkinson J.A., Parsons S., Coxall R.A., Gould R.O., Sadler P.J. J. Am. Chem. Soc. 124:2002;3064.